Brian Mueller - Nov 23, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Nov 23, 2022
Transactions value $
-$293,757
Form type
4
Date filed
11/28/2022, 08:42 PM
Previous filing
Aug 9, 2022
Next filing
Dec 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$88.8K -934 -3.04% $95.09 29.8K Nov 23, 2022 Direct F1
transaction BMRN Common Stock Sale -$94K -945 -3.17% $99.50 28.8K Nov 23, 2022 Direct F1
transaction BMRN Common Stock Options Exercise $237K +3.5K +12.13% $67.81 32.3K Nov 23, 2022 Direct F1
transaction BMRN Common Stock Sale -$348K -3.5K -10.82% $99.50 28.8K Nov 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -3.5K -48.2% $0.00 3.76K Nov 23, 2022 Common Stock 3.5K $67.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.